Kimberly R Jordan

21PUBLICATIONS

146CO-AUTHORS

Predictive and prognostic markersMolecular targetsInnate immunityGenomics and transcriptomicsCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 18, 2026

Cross-assay RNA modeling reveals cancer biomarkers.

|Dec 04, 2025

SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.

Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto

|Oct 31, 2025

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Aug 13, 2024

EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.

Lily L Nguyen, Zachary L Watson, Raquel Ortega

|Aug 08, 2024

The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.

Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post

|Jun 13, 2024

A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.

Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford

Pageof 4

Frequent Collaborators

Benjamin G Bitler

Elizabeth R Woodruff

Tomomi M Yamamoto

Lily L Nguyen

Kian Behbakht

Edward B Chuong

Courtney A Bailey

Francis To

Zachary L Watson

Raquel Ortega

Frequent Collaborators

Benjamin G Bitler

Elizabeth R Woodruff

Tomomi M Yamamoto

Lily L Nguyen